ICYMI: GameStop, Omeros, Congress Impacts Biotechs


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


In case you missed it, here are some of Benzinga's top stories from Thursday, March 22, 2018.

GameStop’s Turnaround Progress

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

With GameStop Corp (NYSE:GME) reporting its Q4 results next week, analysts at Loop Capital took a look at how the company might turn a few heads this year under the helm of its new CEO. Learn more, in Bill Haddad’s “Analyst Says GameStop's Turnaround Strategy, Share Buybacks Could Alleviate 'Depressed' Valuation.”

Congress Action Becomes a Tailwind For Omeros

While markets haven’t been too positive on news out of Washington lately, shares of Omeros Corporation (NASDAQ:OMER) soared Thursday as investors saw positive implications for the company in the latest funding measure to come out of Congress. Get a deeper look at how the stock reacted in “Omeros Spikes 37% Amid Favorable Medicare Policy In Congressional Spending Bill.”

Omeros isn’t the only biotech that could be affected by the Congressional spending bill. Wayne Duggan reports on the effect on stocks like Pfizer Inc (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) , in “Biotech Winners And Losers From Congress' Latest Funding Bill.”


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorNewsHealth CarePreviewsPoliticsPre-Market OutlookTrading IdeasGeneral